30
Participants
Start Date
November 6, 2015
Primary Completion Date
January 16, 2018
Study Completion Date
January 4, 2019
Ganaxolone
oral suspension or capsules
Center for Rare Neurological Diseases, Norcross
Nationwide Children's Hospital, Columbus
JWM Neurology, Indianapolis
Phoenix Children's Hospital, Phoenix
University of California San Francisco, San Francisco
Sutter Institute for Medical Research, Sacramento
Boston Children's Hospital, Boston
Northeast Regional Epilepsy Group, Hackensack
Institute of Neurology and Neurosurgery at St. Barnabas, Livingston
Bambino Gesu Children's Hospital, IRCCS, Rome
Lead Sponsor
Marinus Pharmaceuticals
INDUSTRY